CANCER CARE ONTARIO has a total of 17 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Canada, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, measurement and medical technology are AROS APPLIED BIOTECHNOLOGY APS, ONCOMETHYLOME SCIENCES SA and CONEXIO GENOMICS PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Australia | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Medical technology | |
#4 | Pharmaceuticals | |
#5 | Computer technology |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Medical preparations | |
#4 | Diagnosis and surgery | |
#5 | Electrotherapy | |
#6 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Greenwood Celia | 12 |
#2 | Cotterchio Michelle | 12 |
#3 | Montpetit Alexandre | 12 |
#4 | Zanke Brent W | 12 |
#5 | Gallinger Steven | 12 |
#6 | Phillips Michael | 12 |
#7 | Hudson Thomas J | 12 |
#8 | Ferretti Vincent | 12 |
#9 | Sundararajan Saravanan | 11 |
#10 | Laflamme Phillippe | 10 |
Publication | Filing date | Title |
---|---|---|
WO2008106785A1 | Assessment of risk for colorectal cancer | |
WO2007140599A1 | Assessment of risk for colorectal cancer | |
CA2579588A1 | Assessment of risk for colorectal cancer | |
CA2547824A1 | Assessment of risk for colorectal cancer | |
US6904125B2 | Phantom for evaluating nondosimetric functions in a multi-leaf collimated radiation treatment planning system | |
CA2488413A1 | Eef1a2 for use in the prognosis, diagnosis and treatment of cancer |